Workflow
嘉和美康: 嘉和美康关于股东权益变动触及5%整数倍的提示性公告
Zheng Quan Zhi Xing·2025-07-04 16:35

Core Viewpoint - The announcement details a change in shareholder equity for Jiahe Meikang (Beijing) Technology Co., Ltd., specifically regarding the shareholding of Guoshou Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership), which has reduced its stake to 10.00% following a series of share transactions and stock incentive plans [1][2][3]. Summary by Sections 1. Basic Information of the Shareholder - Guoshou Chengda is a limited partnership with a registered capital of 12.01 billion yuan, primarily engaged in equity investment and asset management [1]. - The partnership was established on November 11, 2016, and is managed by Guoshou Chengda (Shanghai) Health Medical Equity Investment Management Co., Ltd. [1]. 2. Details of the Equity Change - Guoshou Chengda executed a share reduction plan, resulting in a total reduction of 3,053,509 shares, bringing its holdings down to 13,758,560 shares, which is 10.00% of the total share capital [2][3]. - The total share capital of the company has changed from 137,877,502 shares to 137,585,598 shares due to the issuance of restricted stocks and stock options [2][3]. 3. Shareholding Situation Before and After the Change - Before the equity change, Guoshou Chengda held 19,569,619 shares, representing 14.1935% of the total share capital [3]. - After the equity change, Guoshou Chengda's holdings decreased to 13,758,560 shares, which is 10.00% of the total share capital [3]. 4. Future Matters - The equity change aligns with previously disclosed plans and commitments by the shareholder [2]. - The company will continue to comply with relevant disclosure regulations and ensure timely updates to investors regarding any further changes [2].